Flynn James E 13D/13G Filings for Inozyme Pharma, Inc. (INZY)

Flynn James E 13D and 13G filings for Inozyme Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-10
10:03 am
Sale		 2022-12-31 13G Inozyme Pharma, Inc.
INZY		 Flynn James E 0
0.000%		 -2,344,786decrease
(Position Closed)		 Filing
2022-02-11
4:37 pm
Purchase		 2021-12-31 13G Inozyme Pharma, Inc.
INZY		 Flynn James E 2,344,786
9.910%		 1,194,487increase
(+103.84%)		 Filing
2020-08-06
10:58 am
Purchase		 2020-07-28 13G Inozyme Pharma, Inc.
INZY		 Flynn James E 1,150,299
5.150%		 1,150,299increase
(New Position)		 Filing